Keratin 8 (K8) and keratin 18 (K18) are the most common and characteri
stic members of the large intermediate filament gene family expressed
in 'simple' or single layer epithelial tissues of the body. Their pers
istent expression in tumor cells derived from these epithelia has led
to the wide spread use of keratin monoclonal antibodies as aids in the
detection and identification of carcinomas. Oncogenes which activate
ras signal transduction pathways stimulate expression of the K18 gene
through transcription factors including members of the AP-1 (jun and f
os) and ETS families. The persistent expression of K8 and K18 may refl
ect the integrated transcriptional activation of such transcription fa
ctors and, in the cases of ectopic expression, an escape from the supp
ressive epigenetic mechanisms of DNA methylation and chromatin condens
ation. Comparison of the mechanisms of transcriptional control of K18
expression with expression patterns documented in both normal and path
ological conditions leads to the proposal that persistent K8 and K18 e
xpression is a reflection of the action of multiple different oncogene
s converging on the nucleus through a limited number of transcription
factors to then influence the expression of a large number of genes in
cluding these keratins. Furthermore, correlation of various tumor cell
characteristics including invasive behavior and drug sensitivity with
K8 and K18 expression has stimulated consideration of the possible fu
nctions of these proteins in both normal development and in tumorigene
sis. Recent developments in the analysis of the functions of these int
ermediate filament proteins provide new insights into diverse function
s influenced by Kg and K18.